CBIs 4th Annual Medical Device and Diagnostic Marketing Compliance Congress
|Event Date/Time: Jun 17, 2008|
In 2007, the medical device industry came under tremendous scrutiny due to the deferred prosecution agreements in the orthopedics industry. At this event, hear directly from three CCOâ€™s involved in the DPAâ€™s including Zimmer, Smith & Nephew, and Biomet, Inc. Additionally, hear from Smith & Nephewâ€™s Federal Monitor, David Samson, Senior Partner at Wolff and Samson, and Former Attorney General, New Jersey, on the ongoing monitoring and Corporate Integrity Agreements that resulted from these agreements.
Featured Government Perspectives From:
â€¢ U.S. Food and Drug Administration
â€¢ Office of the United States Attorney for the Eastern District of Pennsylvania
â€¢ Office of the United States Attorney for the District of Massachusetts
â€¢ Office of the United States Attorney for the District of New Jersey
PLUS! Engage in ground-breaking, confidential discussions on the strategic issues and challenges CCOs are facing today at CBIâ€™s Invitation-Only Medical Device and Diagnostics Chief Compliance Officer Breakfast, Wednesday June 18, 2008, 7:30-9:00 a.m.